GRIK1 Protein - Glutamate Receptor Kainate Type Subunit 5
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GRIK1 Protein - Glutamate Receptor Kainate Type Subunit 5</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Glutamate receptor kainate 5</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>GRIK1</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P39086</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~103 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Plasma membrane, synapses</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Ionotropic glutamate receptor (kainate)</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Selective antagonists</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Positive allosteric modulators</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Experimental</td>
</tr>
<tr>
<td class="label">RNA-based therapeutics</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">6 edges</a></td>
</tr>
</table>
Grik1 Protein Glutamate Receptor Kainate Type Subunit 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
GRIK1 Protein (GluR5/Kainate receptor subunit 5) is a protein encoded by the GRIK1 gene. It is a subunit of the kainate-type ionotropic glutamate receptor. [@vincent2004]
Structure
Kainate receptors are tetrameric ligand-gated ion channels. Each subunit contains:
- Extracellular N-terminus - Glutamate binding domain
- Three transmembrane domains (M1, M3, M4)
- Intracellular C-terminus - Important for trafficking and regulation
- Flip/flop alternative splicing - Determines desensitization kinetics
Normal Function
Synaptic Transmission
- Mediates slow excitatory postsynaptic currents
- Located at both presynaptic and postsynaptic sites
- Regulates neurotransmitter release
Neuronal Excitability
- Contributes to membrane depolarization
- Modulates neuronal firing patterns
- Influences network oscillations
Synaptic Plasticity
- Involved in [LTP](/mechanisms/long-term-potentiation) and LTD
- Activity-dependent trafficking
- Homeostatic plasticity mechanisms
Role in Disease
Alzheimer's Disease
- Altered expression in AD brain regions
- Interaction with [amyloid-beta](/proteins/amyloid-beta) pathology
- Potential therapeutic target
Epilepsy
- Mutations cause epileptic encephalopathy
- Kainate receptors are proconvulsant
- Drug target for anticonvulsants
Psychiatric Disorders
- Dysregulation in schizophrenia
- Role in mood disorders
Therapeutic Targeting
Agonists
- Glutamate - endogenous agonist
- Kainic acid - potent agonist (used experimentally)
Antagonists
- UBP310 - selective GRIK1 antagonist
- LY466365 - neuroprotective in models
Clinical Applications
- Anticonvulsant drugs target kainate receptors
- Neuroprotective strategies
Key Publications
Lerma J, et al. (2001). 'Kainate receptor pharmacology.' Physiological Reviews. PMID: 11274345(https://pubmed.ncbi.nlm.nih.gov/11274345/)
Contractor A, et al. (2001). 'Kainate receptors: subunits, trafficking, and function.' Neuron. PMID: 14579411(https://pubmed.ncbi.nlm.nih.gov/14579411/)See Also
- [GRIK1 Gene](/proteins/grik1)
- [Glutamate Receptors](/glutamate-receptors-in-neuronal-function)
- [Kainate Receptors](/entities/kainate-receptors)
- [Ionotropic Glutamate Receptors](/entities/ionotropic-glutamate-receptors)
- [Synaptic Transmission](/mechanisms/synaptic-transmission)
External Links
- [UniProt: P39086](https://www.uniprot.org/uniprot/P39086)
- [PDB: Structure available](https://www.rcsb.org/)
Background
The study of Grik1 Protein Glutamate Receptor Kainate Type Subunit 5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Expression Pattern
GRIK1 protein (GluR5) shows region-specific expression throughout the central nervous system. High expression is observed in the cerebellar cortex, particularly in Purkinje cells where kainate receptors contribute to synaptic integration and plasticity. The hippocampus demonstrates moderate expression in CA3 pyramidal neurons and dentate gyrus granule cells.
During development, GluR5 expression peaks during early postnatal periods corresponding to active synaptogenesis. This temporal pattern suggests important roles in neural circuit formation and refinement.
Ligand Pharmacology
The pharmacology of GRIK1-containing receptors is complex:
- Kainic Acid: Potent agonist, gives the receptor family its name
- ATPA: Selective agonist for GRIK1-containing receptors
- LY382884: Selective antagonist for GluR5-containing receptors
- CNQX: Non-selective AMPA/kainate receptor antagonist
- NBQX: Competitive antagonist with preference for AMPA receptors
Signaling Mechanisms
Activation of GRIK1 receptors leads to:
- Sodium influx causing membrane depolarization
- Calcium influx (in certain subunit configurations)
- Activation of downstream kinases including PKC and CaMKII
- Modulation of gene transcription through nuclear signaling pathways
The receptors can couple to various intracellular signaling cascades that modulate synaptic plasticity, gene expression, and neuronal survival.
Role in Neurodegeneration
Alzheimer's Disease
In Alzheimer's disease, GRIK1-containing receptors may contribute to excitotoxic pathways. Amyloid-beta can potentiate kainate receptor-mediated currents, leading to dysregulated calcium homeostasis and neuronal vulnerability. Studies show altered GRIK1 expression in AD brain tissue.
Epilepsy
GRIK1 dysfunction is implicated in epilepsy through:
- Dysregulated glutamate signaling
- Enhanced neuronal excitability
- Altered synaptic plasticity in excitatory circuits
Psychiatric Disorders
Evidence suggests GRIK1 involvement in:
- Depression and anxiety disorders
- Autism spectrum disorders
- Schizophrenia
Therapeutic Targeting
Several therapeutic strategies targeting GRIK1 are under investigation:
Protein-Protein Interactions
GRIK1 interacts with multiple proteins:
- PSD-95: Postsynaptic scaffolding protein
- GRIP/GRIP1: AMPA receptor interacting proteins
- PICK1: Protein kinase C interacting protein
- ADP-ribosylation factors: Membrane trafficking
- CASK: Synaptic scaffolding protein
Animal Models
GRIK1 knockout mice display significant phenotypes:
- Reduced seizure susceptibility
- Impaired motor learning
- Altered hippocampal plasticity
- Changes in anxiety-like behavior
- Abnormal social behavior in some studies
Key Publications
[@hu2014]: Hu Y, et al. (2014). "Kainate receptors in s[^5]: Lerma J, et al. (2001). "Kainate receptors: from synaptic plasticity to disease." Brain Research Bulletin. PMID: 11527997(https://pub
References